---
title: "Peptides discussed for Heart, Liver & Kidney"
url: https://humanpeptides.fyi/objectives/organs
site: humanpeptides.fyi
last_reviewed: 2026-10-11
---


# Heart, Liver & Kidney

> humanpeptides.fyi makes no claims of its own. Every statement below reports what a cited source says, with its link. Not medical advice.

Heart, Liver & Kidney: 14 peptides and related compounds in this index have at least one researched benefit that sources link to heart, liver & kidney. Those with approved or trial-backed evidence: Thymosin Alpha-1, Semaglutide, Tesamorelin, Tirzepatide, Retatrutide, HGH (Somatropin), Glutathione.

| Peptide | Evidence label | What sources discuss for this goal |
|---|---|---|
| [Thymosin Alpha-1](https://humanpeptides.fyi/peptides/thymosin-alpha-1) | Trial-backed | Chronic hepatitis B |
| [Semaglutide](https://humanpeptides.fyi/peptides/semaglutide) | Approved (specific use) | Fewer heart attacks and strokes; Kidney and liver protection |
| [Tesamorelin](https://humanpeptides.fyi/peptides/tesamorelin) | Approved (specific use) | Less liver fat in HIV |
| [Tirzepatide](https://humanpeptides.fyi/peptides/tirzepatide) | Approved (specific use) | Blood sugar and heart risk |
| [Retatrutide](https://humanpeptides.fyi/peptides/retatrutide) | Trial-backed | Blood sugar control; Less liver fat |
| [Epithalon](https://humanpeptides.fyi/peptides/epithalon) | Early human | Lower mortality, small Russian trials |
| [TB-500](https://humanpeptides.fyi/peptides/tb-500) | Preclinical | Cardiac repair, preclinical |
| [Lipo-C](https://humanpeptides.fyi/peptides/lipo-c) | Unstudied | Liver fat handling, nutrient data only |
| [MIC](https://humanpeptides.fyi/peptides/mic) | Unstudied | Liver fat export, choline data |
| [Tesamorelin + Ipamorelin](https://humanpeptides.fyi/peptides/tesamorelin-ipamorelin) | Unstudied | Belly fat, via tesamorelin |
| [HGH (Somatropin)](https://humanpeptides.fyi/peptides/hgh) | Approved (specific use) | Less visceral fat, better lipids |
| [Glutathione](https://humanpeptides.fyi/peptides/glutathione) | Trial-backed | Fatty liver, small pilot |
| [FOXO4-DRI](https://humanpeptides.fyi/peptides/foxo4-dri) | Preclinical | Kidney function, mice |
| [5-Amino-1MQ](https://humanpeptides.fyi/peptides/5-amino-1mq) | Preclinical | Metabolic health, mice |

## Questions about heart, liver & kidney

### Which peptides are discussed for heart, liver & kidney?

Thymosin Alpha-1, Semaglutide, Tesamorelin, Tirzepatide, Retatrutide, Epithalon, TB-500, Lipo-C, MIC, Tesamorelin + Ipamorelin, HGH (Somatropin), Glutathione, FOXO4-DRI, 5-Amino-1MQ.

### Which have the strongest evidence for heart, liver & kidney?

Labelled approved or trial-backed: Thymosin Alpha-1, Semaglutide, Tesamorelin, Tirzepatide, Retatrutide, HGH (Somatropin), Glutathione. Approval covers specific uses only.

### Is any of this a recommendation?

No. humanpeptides.fyi makes no claims of its own. Each entry reports what cited sources say, with links. Talk to a licensed clinician.